Niddk: inflammatory and vascular diseases scientific support. Severable.
Active Purchase Order Awarded Last action
- Contract number
- 75N94026P00062
- Awardee
-
Exonova Biosciences LLC UEI DBSRKKLNHV89
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $190,000
Award facts
- Opportunity
-
- Inflammatory and Vascular Diseases Scientific Support Pre-Solicitation · 75N94026Q00012 · Posted Dec 10, 2025
- Contract value 100% obligated
- $190,000.00 Current and potential, with all options
- Completion date 84% complete
- Current and potential, with all options
- Funding agency
- National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $190,000 firm fixed-price purchase order to Exonova Biosciences LLC on January 1, 2026, for scientific support services focused on inflammatory and vascular diseases. The contract, which extends through December 31, 2026, supports the Biomedical and Metabolic Imaging Branch and was awarded without full and open competition under simplified acquisition procedures. The procurement was designated as a Total Small Business set-aside, though the award was ultimately made to the identified small business contractor. The place of performance is located in Bethesda, Maryland.
The contractor is required to provide laboratory-based patient sample testing services with demonstrated expertise in innate immunology and hereditary autoinflammatory diseases. Specific technical capabilities include advanced methodologies such as molecular cloning, exosome engineering, microRNA transfection, induced pluripotent stem cell (iPSC) processing, and single-cell RNA sequencing. This work aligns with NIDDK's mission to support research into metabolic diseases and kidney health, leveraging specialized scientific expertise to advance the agency's research objectives in understanding disease mechanisms at the cellular and molecular level.
Quick answers
Who was awarded contract 75N94026P00062?
75N94026P00062 was awarded to Exonova Biosciences LLC by National Institute of Child Health and Human Development (National Institutes of Health) on January 1, 2026.
How much is contract 75N94026P00062 worth?
The government has obligated $190,000 on 75N94026P00062.
Which agency awarded contract 75N94026P00062?
National Institute of Child Health and Human Development (National Institutes of Health) awarded 75N94026P00062, with funding from National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health).
Was contract 75N94026P00062 competed?
The extent of competition for 75N94026P00062 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award